Only a tenth of prescriptions are truly “up for grabs”? Interesting analysis – Traditional promotion efforts, including details and sampling, can only affect about 10% of prescriptions, an IMS study found, suggesting that the bulk of promotion dollars is misplaced…more
Another gout drug (this one from Savient Pharmaceuticals) approved by FDA – The 14-to-1 vote for approval reflected a general consensus that the effectiveness of the drug in relieving severe pain and disability outweighed the risk of allergic reactions and suggestions that it could cause cardiovascular problems…more
PLUS – UCB Pharma comes up with a plan to report Adverse Events via a community site. This is an important initiative – one of the big excuses pharma company regulators have used to shy away from social networking is the AE canard. This issue can be dealt with, and what UCB is doing will help light the way. Plus, here’s a Washington Post article on how drug companies are delving into the on-line space.
Breaking news: Watson acquiring generics maker Arrow.
Subscribe to the Impactiviti blog via e-mail
Subscribe to the Impactiviti blog via RSS
Connect with Steve Woodruff